Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company also provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. Its technology includes diagnostic and therapeutic. It has developed a novel diagnostic assay for the early and rapid diagnosis of sepsis, based on the detection of molecular signatures of sepsis specific to the immune response, rather than the presence of a pathogen.


CSE:ASEP - Post by User

Post by StockHawk1on May 24, 2022 6:44pm
79 Views
Post# 34705058

Peptide tech

Peptide tech

Asep Medical Holdings' ($ASEP.C $SEPSF) peptide tech allows antibiotics better to penetrate bacteria by destroying the bacteria's outer biofilm layer. 


Therefore their peptide biotech addresses the huge problem that is antibiotic failure head-on.


Bacterial infections like sepsis kill millions every in economically rich and poor countries. Considering this IMO $ASEP's peptide medicine could see huge demand once it is FDA-approved and on the market.  


More here → https://asepmedical.com/technologies/therapeutic/


$ASEP @ $0.30, MC $16.84M

 
<< Previous
Bullboard Posts
Next >>